Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1100_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Contributors
- •Part I
- •Esophageal Surgery
- •Tracheo-Esophageal Fistula
- •Overview
- •Etiology
- •Clinical Presentation
- •Diagnosis
- •Management
- •Conservative Management
- •Endoscopic Management
- •Operative Management
- •Postesophagectomy TEF
- •Postintubation TEF
- •Bronchoesophageal Fistula
- •Prevention of Tracheoesophageal Fistula
- •Outcomes
- •Conclusion
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnose or Manage Complications Intra or Postoperatively
- •References
- •Esophageal Strictures Refractory to Endoscopic Dilatation
- •Introduction
- •Etiology of Esophageal Strictures
- •Treatment
- •Treatment of Benign Esophageal Strictures
- •Nonsurgical Options
- •Endoscopic Dilatation
- •Steroid Injection
- •Esophageal Stenting
- •Rendez-Vous Procedure
- •Incisional Therapy
- •Surgical Options
- •Antireflux Surgery for Peptic Strictures
- •Esophagectomy
- •Malignant Esophageal Strictures
- •Endoscopic Treatment
- •Dilatation
- •Stent Placement
- •Laser Therapy
- •Brachytherapy
- •Chemotherapy and Radiation Therapy
- •Surgical Treatment
- •Conclusion
- •Key Points for Avoiding Postsurgical Esophageal Strictures
- •Key Points for Managing Esophageal Strictures
- •References
- •Esophageal Anastomotic Leak
- •Introduction
- •Risk Factors for Anastomotic Leak
- •Presentation and Identification of a Leak
- •Prevention and Management of Anastomotic Leaks
- •Future Directions
- •Conclusion
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Transhiatal Esophagectomy—Intraoperative Disasters
- •Introduction
- •Preoperative Risk Factors for Bleeding with a THE
- •General Considerations
- •Anesthetic Considerations
- •Conduct of the Operation
- •Bleeding Scenarios During THE
- •Tracheal Tear
- •Summary
- •Key Points: Avoiding Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •Key Points: Diagnosing and Managing Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •References
- •Chyle Leak After Esophageal Surgery
- •Introduction
- •Historical Review
- •Basic Science
- •Embryology
- •Anatomy
- •Physiology
- •Composition of Chyle
- •Chylothorax
- •Etiology/Cause
- •Post-esophagectomy Chylothorax
- •Diagnosis
- •Clinical Features
- •Fluid Studies
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Summary
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Evaluation of the Vocal Cords
- •Treatment of Unilateral Vocal Cord Dysfunction
- •Injection Augmentation
- •Framework Surgery for Unilateral Vocal Cord Dysfunction
- •Treatment of Bilateral Vocal Paralysis
- •Key Summary Points
- •References
- •Introduction
- •Pathophysiology
- •Classification
- •Symptoms
- •Diagnosis
- •Management of Airway, Hoarseness, and Vocal Cord Dysfunction After Esophagectomy
- •Introduction
- •Vocal Fold Dysfunction
- •Symptoms of Unilateral Vocal Cord Dysfunction
- •Symptoms of Bilateral Vocal Cord Dysfunction
- •Treatment
- •Complications
- •Conclusion
- •Five Key Points on How to Avoid Complications
- •Five Key Points on Diagnosing and/or Managing the Complications Either Intraoperatively or Postoperatively
- •References
- •Intraoperative Solutions for the Gastric Conduit that Will Not Reach
- •Colon as an Alternative Conduit
- •Jejunum as an Alternative Conduit
- •Pedicled Jejunal Interposition
- •Free Jejunal Interposition
- •Summary
- •Key Points
- •References
- •Injury to the Right Gastroepiploic Artery
- •Introduction
- •Anatomy of the RGEA
- •Vascular Considerations in Esophagectomy
- •Preoperative Evaluation of the RGEA
- •Preparation and Mobilization of the Gastric Conduit
- •Techniques for Improving Tissue Oxygenation
- •Tension-Free Anastomosis
- •“Supercharging”
- •Venous Drainage
- •Conclusion
- •Five Key Points: Avoiding Injury to the Right Gastroepiploic Artery
- •References
- •Intra-Operative Solutions for Ischemic Gastric Conduit
- •Gastric Esophageal Replacement Conduit
- •Diagnosis of Gastric Conduit Ischemia
- •Summary
- •Key Points for Avoiding Gastric Conduit Necrosis
- •Key Points for Managing Gastric Conduit Necrosis Postoperatively
- •References
- •Jejunal Feeding Tube Complications
- •Introduction
- •Technique for Placement
- •Open Surgical Jejunostomy Tubes
- •Laparoscopic Jejunostomy Tubes
- •Complications
- •Bowel Necrosis
- •Bowel Obstruction
- •Tube Dysfunction
- •Infectious Complications
- •Aspiration
- •Conclusion
- •Key Points
- •References
- •Part II
- •Gastric Surgery
- •Gastroparesis
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Bile Reflux
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Conclusion
- •Key Points (Prevention)
- •Key Points (Management)
- •References
- •Dealing with Dumping Syndrome
- •Introduction
- •Diagnosis
- •Prevention
- •Management of Dumping Syndrome
- •Diet
- •Pharmacologic Therapy
- •Acarbose
- •Somatostatin Analogs
- •Studies of the Fast-Acting Somatostatin Analog Octreotide
- •Studies of Long-Acting Octreotide LAR
- •Adverse Effects of Somatostatin Analogs
- •Surgical Treatment
- •Conversion of Billroth II to Billroth I Anastomosis
- •Roux-en-Y Conversion
- •Continuous Enteral Feeding
- •Conclusion
- •Key Points
- •References
- •Introduction
- •Epidemiology
- •Etiology
- •Pathophysiology
- •Clinical History
- •Physical Findings
- •Differential Diagnosis
- •Diagnosis
- •Noninvasive Imaging Studies
- •Treatment
- •Medical Treatment
- •Endoscopic/Interventional Radiology
- •Surgical Intervention
- •Summary
- •Key Points for Avoiding
- •Key Points for Diagnosing/Managing
- •References
- •Duodenal Stump Blowout
- •Introduction
- •Clinical Presentation of Blowout
- •Mechanisms Contributing to Blowout
- •Staple Line Failure
- •Distal Obstruction
- •Malnutrition
- •The Difficult Duodenum
- •Techniques for Reducing the Risk of Blowout
- •Management of the Difficult Duodenum
- •General Principles of Closure
- •Nissen Technique
- •Bancroft Technique
- •Tube Duodenostomy and Drainage
- •Management of Stump Blowout
- •Medical Management
- •Percutaneous Radiologic Techniques
- •The Decision to Operate and Surgical Approach
- •Summary of Management
- •Ramifications of Blowout
- •Conclusions
- •Key Points: Avoiding Duodenal Stump Blowout
- •Key Points: Diagnosing and Managing Stump Blowout
- •References
- •Postoperative Complications After Surgery for Gastric Cancer: Anastomotic Leakage
- •Introduction
- •Incidence
- •Prospective Factors
- •Detection
- •Differential Diagnosis
- •General Management
- •External Drainage
- •Treatment of the Leakage Site
- •Duodenal Stump Leakage
- •Summary
- •Five Key Points to Avoid Anastomotic Leakage
- •Five Key Points to Diagnose and Manage Leakage
- •References
- •Part III
- •Hepatobiliary and Pancreatic Surgery
- •Introduction
- •Definition of PHI
- •Risk Factors for PHI
- •Prevention of PHI
- •Systematic Volumetry of the “Fully Functioning” Part of the Liver
- •Portal Vein Embolization
- •Limiting the Duration of Preoperative Chemotherapy
- •Treatment of PHI
- •Conclusion
- •Key Points
- •References
- •Biliary Leaks and Thoracobiliary Fistula
- •Introduction
- •Definitions
- •Biliary Leak and Grading System
- •Controlled and Uncontrolled Biliary Leaks
- •Source
- •Risk Factors and Prevention
- •Prevention
- •Risk Factors for Bile Leaks After Extrahepatic Bilioenteric Anastomosis
- •Prevention
- •Risk Factors for Bile Leak After Liver Resection
- •Prevention of Biliary Leaks After Hepatectomy
- •Intraoperative Tests for Bile Leaks
- •Postoperative Drains
- •Diagnosis
- •Investigations
- •Ultrasonography or CT Scan
- •Fistulogram
- •MRC, ERC, and PTC
- •HIDA
- •Management
- •Medical Management
- •Endoscopic Management
- •Interventional Radiology
- •Combined Endoscopic and Interventional Radiology Approaches—Rendezvous Procedures
- •Thoracobiliary Fistula
- •Diagnosis
- •Treatment
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnosis or Manage Complications
- •References
- •Contralateral Bile Duct Injury During Hepatic Resection
- •Introduction
- •Etiology and Risk Factors
- •Anatomical Variations
- •Difficult Surgical Resection and Reoperation
- •Type of Liver Resection
- •Aggressive Dissection and Devascularization of Bile Ducts
- •Initial Investigations and Management
- •Initial Investigations
- •Stabilization and Operative Planning
- •No Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction but no Fistula
- •Definitive Management
- •Anatomy Relevant to Operative Repair of Biliary Outflow of Remnant
- •Operative Repair
- •Repair of Injury to Right Liver Outflow
- •Repair of Injury to Left Liver Outflow
- •Prevention of Contralateral Bile Duct Injury
- •Attention to Variation in Biliary
- •Intrahepatic Control of Biliary Radicals
- •Tumor Close to the Hilum
- •Outcomes
- •Five Key Points to Avoid Contralateral Bile Duct Injury
- •Five Key Points to Diagnose and Treat Contralateral Bile Duct Injury
- •References
- •Massive Intraoperative Hemorrhage During Hepato-Biliary and Pancreatic Surgery
- •Introduction
- •Hemorrhage During Liver Surgery
- •Magnitude of Problem
- •Hepatic Vascular Anatomy
- •Prevention of Major Hemorrhage During Hepatic Resection
- •Techniques Aimed at Reducing Blood Loss During Hepatic Surgery
- •Deliberate Dissection and Exposure of Retro-Hepatic Vena Cava and Major Hepatic Veins
- •Hepatic Inflow Control
- •Vascular Isolation
- •Acute Normovolemic Hemodilution (ANH)
- •Management of Intra-Operating Bleeding During Liver Resection
- •Massive Hemorrhage During Pancreatic Surgery
- •Pancreatic Anatomy
- •Bleeding During Pancreaticoduodenectomy
- •Summary
- •5 Key Points to Avoid Complications
- •References
- •Intraoperative Injury to Hepatic Arterial Structures
- •Introduction
- •Normal Anatomy of the Hepatic Arterial Vasculature
- •Variant Anatomy of the Hepatic Arterial Vasculature
- •Replaced and Accessory Right Hepatic Arteries
- •Replaced and Accessory Left Hepatic Arteries
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Preoperative Radiographic Assessment
- •Preoperative Considerations
- •Intraoperative Considerations
- •Specific Intraoperative Considerations
- •Pancreaticoduodenectomy (PD)
- •Replaced/Accessory Right Hepatic Artery
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Hemi-hepatectomy
- •Conclusions
- •Key Points: Preoperative Interventions
- •Key Points: Intraoperative Principles
- •References
- •Hepatic Abscess
- •Etiology
- •Diagnosis
- •Computed Tomography
- •Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Five Key Points on How to Avoid Complications
- •Five Separate Key Points on Diagnosing and/or Managing the Complication
- •References
- •Hepaticojejunostomy Anastomotic Strictures
- •Introduction
- •Diagnosis
- •Clinical and Biological Presentation
- •Morphological Evaluation
- •Incidence and Risk Factors According to the Clinical Context
- •Iatrogenic Bile Duct Injury
- •Liver Transplantation (LT)
- •Pancreatic Head Resection
- •Choledochal Cyst
- •Therapeutic Options
- •Conservative Management
- •Choice of the Approach
- •To Stent or Not to Stent?
- •Periprocedural Management
- •Surgery
- •Revisionary Surgery
- •Liver Resection
- •Liver Transplantation (LT)
- •Key Points: How to Avoid HJ Stricture
- •Key Points: Diagnostic and Management
- •References
- •Defining Pancreatico-Jejunostomy Strictures (PJS) and Pancreatico-Jejunostomy Strictures (PGS) by Symptoms, Morphology and Function
- •Management of Intractable Pain Due to PJA or PGS Stenosis in Surgical Case Series
- •Endoscopic Techniques for Management of PJA Strictures
- •Technical Clinical Results for ERP
- •EUS-Guided Access and Drainage
- •EUS-Guided Rendezvous
- •Pancreatic Antegrade Needle Knife (PANK) Technique
- •EUS-Guided Pancreatogastrostomy
- •Jejunal Stenosis Mimicking PJA Stenosis
- •Conclusions
- •Key Points
- •References
- •Postoperative Portal, Mesenteric, and Splenic Vein Thrombosis
- •Introduction
- •Pathophysiology
- •Diagnosis: Clinical Manifestations and Blood Tests
- •Diagnosis: Imaging Tests
- •Treatment
- •Anticoagulation
- •Interventional Techniques
- •Surgery
- •Conclusion
- •Key Points for Diagnosis
- •Key Points for Treatment
- •References
- •Postpancreatectomy Hemorrhage: Early and Late
- •Introduction
- •Prevention of Late PPH
- •The Falciform Ligament
- •The Portal Dissection
- •GDA Ligation
- •Reinforcing the Pancreatic Transection Site (Distal Pancreatectomy)
- •Diagnosis of Late PPH
- •Symptoms/Signs
- •Imaging for Late PPH
- •Management of PPH
- •Early PPH
- •Late PPH
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points to Diagnose/Manage
- •References
- •Major Disruptions of Pancreaticojejunostomy
- •Introduction
- •Conclusion
- •Key Points: How to Avoid Complications
- •Key Points: Diagnosis/Management
- •References
- •Persistent Pancreatic Fistula
- •Introduction
- •Definition of Pancreatic Fistula
- •Procedure-Specific Incidence and Risk Factors for Pancreatic Fistula
- •Pancreaticoduodenectomy
- •Distal Pancretectomy
- •Duodenum-Preserving Pancreatic Head Resection/Lateral Pancreaticojejunostomy
- •Pancreatic Pseudocyst Drainage/Pancreatic Necrosectomy
- •Other Pancreatic Resections
- •Prevention of Pancreatic Fistula
- •Complications of Pancreatic Fistula
- •Management of Pancreatic Fistula
- •Initial Management
- •Delineation of Pancreatic Duct
- •Definitive Treatment of Pancreatic Fistula
- •Operative Management of Pancreatic Fistula
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points: Diagnosing and/or Managing Complications Either Intra- or Postoperatively
- •References
- •Management of Chyle Leaks Following Pancreatic Resection
- •Introduction
- •Background
- •Anatomy and Physiology of Visceral Lymphatics
- •Diagnosis of a Chyle Leak
- •Management of a Chyle Leak
- •The Contained Chyle Leak
- •Chylous Ascites
- •Management of Refractory Chyle Leaks
- •Conclusion
- •Key Points in Managing a Chyle Leak
- •References
- •Overview
- •Diagnosis
- •Prevention
- •Identifying Risk Factors
- •Role of Octreotide
- •Role of Pancreatic Stenting
- •Dissection and Management of the Pancreatic Stump
- •Minimally Invasive Versus Open Techniques
- •Drain Placement and Management
- •Management of Complications of Pancreatic Leak
- •Goal-Directed Resuscitation and Infection Control
- •Further Definition of Anatomy and Source Control
- •Optimizing Patient Clinical Status for Ongoing Conservative Management
- •Deliberate Reintervention When Clinically Indicated
- •Summary
- •Key Points on Avoiding Complications
- •Key Points on Diagnosis/Management of Complications
- •References
- •Part IV
- •Colorectal Surgery
- •Pearls for the Small Bowel and Colon That Will Not Reach
- •Introduction
- •Anatomic Constraints
- •Diagnosing the Problem
- •Specific Techniques: Making It Reach
- •Colorectal and Coloanal Anastomosis
- •Lateral-to-Medial Approach
- •Medial-to-Lateral Approach
- •Ileal-Pouch Anal Anastomosis (IPAA)
- •Stomas that Do Not Reach
- •Bailout Maneuvers—It Just Does Not Reach
- •Conclusions
- •Key Points on How to Avoid the Complication
- •Key Points on Diagnosing/Managing the Complication
- •References
- •Anastomotic Leak/Pelvic Abscess
- •Introduction
- •Prevention
- •Diagnosis and Management
- •Diagnosis
- •Management
- •Type I: Generalized Peritonitis
- •Type II: Localized Pelvic Abscess
- •Type III: Fistula
- •Long-Term Outcome
- •Need for a Permanent Stoma
- •Stenosis or Stricture
- •Local Recurrence
- •References
- •Management of Anastomotic Stricture
- •Introduction
- •Etiology of Anastomotic Stricture
- •Presentation and Diagnosis
- •Nonoperative Treatment
- •Balloon Dilation and Endoscopic Options
- •Stents
- •Operative Treatment
- •Reoperative Surgery
- •Anastomotic Revision and Diverting Stomas
- •New Technology
- •Conclusion
- •To Avoid Anastomotic Strictures in Colorectal Resections
- •Five Points on Diagnosing and Managing Anastomotic Strictures
- •References
- •Intraoperative Ureteral Injury
- •Introduction
- •Role of Preoperative Stenting
- •Incidence of Ureteric Injury and Early Identification of Injury
- •Placement of Ureteral Stents
- •Detection of Ureter Injury
- •Management of Ureter Injury
- •Proximal Third Injuries
- •Middle Third Ureteral Injuries
- •Lower Third Ureteral Injuries
- •Delayed Ureteral Transection or Ligation
- •Management Post Repair
- •Outcomes
- •Key Points to Avoiding Injury
- •Key Points to Diagnosis and Manage the Complication
- •References
- •Introduction
- •Anatomy
- •Incidence
- •Types of Prostatic Urethral Injury
- •Prevention
- •Detection
- •Management
- •Delayed Rectourethral Fistula
- •Conclusion
- •Key Points on Avoiding Complications
- •Key Points on Diagnosing/Managing Prostatic Urethral Injuries
- •References
- •Vaginal Injury During Stapled Anastomosis
- •Introduction
- •How to Avoid Vaginal Injury
- •How to Fix Vaginal Injury
- •Key Points on How to Avoid Vaginal Injury
- •Management of Rectovaginal Fistula
- •Introduction
- •General Principles
- •Local Repair
- •Mucosal Advancement Flap Repair
- •Endorectal Advancement Flap with Muscular Plication (Anterior Levatorplasty)
- •Transanal Sleeve Advancement Flap
- •Transvaginal Repair
- •Fistulotomy
- •Ligation of Intersphincteric FistulaTract
- •Biological Agents: Fibrin Glue and Fistula Plug
- •Miscellaneous
- •Tissue Transfer Procedures
- •Gracilis Muscle Interposition Flap
- •Martius Flap
- •Abdominal Procedure
- •Transperineal Omental Flap
- •Perioperative Management
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points on Diagnosis and/or Managing Complications
- •References
- •Management of Presacral/Pelvic Bleeding
- •Introduction
- •Anatomy
- •Patterns of Injury
- •Management
- •Role of the Anaesthesiologist
- •Role of the Surgeon
- •Minimal-Access Surgery
- •The Postoperative Period
- •Summary
- •Key Points
- •References
- •Introduction
- •Preoperative Evaluation
- •Medical Comorbidities
- •Radiation Therapy
- •Chemotherapy
- •Imaging
- •Timing of Reconstruction
- •Classification of Defect
- •Reconstructive Surgical Tenants
- •Adjuncts to Flap Surgery
- •Negative Pressure Wound Therapy
- •Tissue Expansion
- •Biologic Tissue Matrices
- •Rectus Abdominis Muscle
- •Gracilis Muscle Flap
- •Gluteus Maximus Muscle
- •Pudendal Flap
- •Anteriolateral Thigh Flap
- •Postoperative Care
- •Ambulation
- •Drain Management
- •Complications
- •Summary
- •Key Points: Preventing Complications
- •Key Points: Managing Complications
- •References
- •Complications After TEM (Transanal Endoscopic Microsurgery) and TAMIS (Transanal Minimally Invasive Surgery)
- •Background
- •Complications of TEM and TAMIS
- •Postoperative Fever
- •Wound Dehiscence
- •Rectal Pain
- •Peritoneal Perforation
- •Pelvic Phlegmon and Abscess
- •Fistula
- •Bleeding
- •Incontinence
- •Conclusion
- •Key Points: Avoiding a Complication
- •Key Points: Managing/Diagnosing Septic Complications
- •References
- •Parastomal Hernia
- •Overview
- •Definition and Classification
- •Incidence
- •Pathophysiology
- •Risk Factors
- •Complications
- •Prevention
- •Preoperative Considerations
- •Operative Considerations
- •Diagnosis
- •History and Physical Exam
- •Imaging
- •Management
- •Nonoperative Management
- •Operative Management
- •Open Approach
- •Laparoscopic Approach
- •Postoperative Complications
- •Management of Recurrent Parastomal Hernias
- •Key Points: Diagnosing/Managing Parastomal Hernia
- •Key Points: Avoiding Parastomal Hernia Complications
- •References
- •Stoma Retraction/Ischemia/Stenosis
- •Introduction
- •Etiology/Incidence/Risk Factors
- •Prevention
- •Recognition/Assessment/Severity/Therapy
- •Conclusions
- •Five Keys Points in Diagnosing and Managing Stenosis, Retraction, and Ischemia in an Ostomy
- •Five Key Points on How to Avoid Tension and Ischemia in an Ostomy
- •References
- •Incontinence After Lateral Internal Sphincterotomy/Fistulotomy
- •Introduction
- •Lateral Internal Sphincterotomy
- •Fistulotomy
- •Management
- •Evaluation
- •Treatment
- •Injectables
- •Magnetic Bowel Sphincter
- •Sacral Nerve Stimulator
- •Artificial Bowel Sphincter
- •Diversion
- •Key Points: Strategies to Avoid the Complication of Incontinence
- •Key Points: Diagnosing and/or Managing the Complication of Incontinence Either Intraoperatively or Postoperatively
- •References
- •Anal Stenosis After Hemorrhoidectomy: Avoidance and Management
- •Introduction
- •Diagnosis
- •Classification of Stenosis
- •Treatment
- •Prevention
- •Nonoperative Intervention
- •Operative Intervention
- •Anatomic Versus Functional Stenoses
- •Preoperative Planning
- •Postoperative Care
- •Summary
- •Key Points: Managing Complications
- •References
- •Part V
- •Other Considerations
- •Delivering Bad News: Conversations with My Surgeon
- •Introduction
- •Informed Consent
- •The Family Does Not Want the Patient to be Fully Informed
- •Perioperative Death
- •When an Intraoperative Death Does Occur
- •Discussion of Unresectability or Metastatic Disease that Precludes Resection
- •Discussion of a Postoperative Complication
- •Discussion of the Unanticipated Major Postoperative Complication
- •Discussion of Operative Findings
- •The Need for Reoperation
- •Complications that Occur in your Absence from the Hospital
- •Withdrawal of Life-Sustaining Measures
- •Discussing the Pathology Report
- •Discussion of Long-term Survival Prospect
- •Management of the Difficult Family
- •References
- •Index

Preventing Pancreatic
Fistula Following Distal
Pancreatectomy
Bharath D. Nath and Mark P. Callery
30
Overview
Postoperative pancreatic fistula (POPF) is a
feared complication following distal pancreatectomy that contributes significantly to patient morbidity and mortality. While the majority of POPF
can be managed conservatively, the presence of
pancreatic fistula is a risk factor for the development of intra-abdominal sepsis and post-pancreatectomy hemorrhage, which individually can
be life threatening. Estimates of the incidence of
pancreatic fistula following distal pancreatectomy range widely. Some centers report rates under
10 %, while others report POPF in close to 50 %
of patients undergoing distal pancreatectomy. To
some extent, this variation may be secondary to
the method used to diagnose POPF. Uncontrolled
pancreatic fistula, while less common, is the most
dangerous and can evolve into other complications, such as pancreatic pseudocyst and abscess.
The incidence of pseudocyst as a complication of
distal pancreatectomy is between 1 and 2 %. In
one series of patients who underwent distal pancreatectomy for trauma, 2 of 72, or about 2.7 %,
developed pancreatic pseudocyst postoperatively
[1].
Numerous investigations, analyses, and clini-
cal trials devoted to identifying risk factors for
M. P. Callery () · B. D. Nath
Department of Surgery, Beth Israel Deaconess Medical
Center, Harvard Medical School, 330 Brookline Avenue,
Boston, MA 02215, USA
e-mail: mcallery@bidmc.harvard.edu
B. D. Nath
e-mail: bnath@bidmc.harvard.edu
POPF have been reported and have guided strategies for its management and prevention. A short
list of risk factors for the development of POPF
includes pancreatic texture, pathology, duct size,
age, intraoperative blood loss, and others [2]. A
number of technical factors have also been investigated. Few of these, however, have been demonstrated to have an effect on the overall incidence of POPF, understandably to the frustration
of surgeons and their patients [3]. This chapter
considers proposed interventions for the reduction of POPF that have been evaluated in the
preoperative, intraoperative, and postoperative
settings.
Diagnosis
The consensus classification scheme devised by
the International Study Group on Pancreatic Fistula (ISGPF) in 2005 divides pancreatic fistula
into three grades. In general terms, POPF is defined as leakage of pancreatic secretions from the
pancreatic parenchyma or a disrupted pancreatic
duct stump or anastomosis. The leak may result
in the formation of a pseudocyst, may be drained
externally via a surgical drain, or may communicate with another epithelialized surface [4]. However, it is important to note that if there is high
drain output, even a high-output pancreatic fistula may have no obvious abnormality on crosssectional imaging. Clinically, the diagnosis of
POPF may be heralded by a variety of symptoms
and consequently should be considered in nearly
all cases wherein a patient’s clinical course deviates from what is expected. Drain character may
T. M. Pawlik et al. (eds.), Gastrointestinal Surgery, DOI 10.1007/978-1-4939-2223-9_30,
© Springer Science+Business Media New York 2015
317

318 B. D. Nath and M. P. Callery
become cloudy and grayish, which is characteristic of POPF. Amylase levels collected from the
drain or collection on or after postoperative day
#3 must be three times the upper limit of normal
to define a leak according to the ISGPF classification. Patients with pancreatic fistula have a
spectrum of presentation, from patients that appear well and are unlikely to have significant
sequelae from the POPF (grade A), to patients
that appear ill, with signs of sepsis and risk of
death, and a high likelihood of reintervention and
persistent drainage (grade C). Grade B falls between these extremes and, in general, are patients
with signs of infection, with persistent drainage,
who typically require admission and inpatient
management, but who typically do not require
interventional procedures and who do not appear
septic [4]. Since its publication, the ISGPF classification scheme has been validated as a useful
clinical tool, as well as a predictor of increased
hospital costs, particularly in a cohort of patients
undergoing pancreaticoduodenectomy [5].
Even this scheme, however, is not without
limitations. Perhaps most importantly, one large
series identified a latent presentation of pancreatic fistula occurring in 3.2 % of patients undergoing distal pancreatectomy. In these patients,
initial drain output was notable for normal or
minimally elevated amylase levels that did not
meet biochemical criteria for pancreatic fistula
by ISGPF definitions. Subsequently, all these
patients had the diagnosis of pancreatic fistula
confirmed by clinical or radiographic investigation. Patients with latent fistula were more likely
to have superimposed infection versus clinically
evident fistula [6].
Although drain amylase measurement has
been the standard since the ISGPF consensus
statement, recent investigations have suggested
that drain lipase may be equally effective at detecting fistulas and possibly superior in terms of
sensitivity and specificity in detecting clinically
relevant fistulas [7].
Another limitation arises from the broad classification of pancreatic fistula from all operations
within the ISGPF system. Recent work has suggested that there was little difference in clinical
impact between grade B and C pancreatic fistula
among patients undergoing distal pancreatectomy, as well as only marginally increased hospital
costs, versus robust increases in hospital costs
between patients who had grade B and C fistula
following pancreaticoduodenectomy [8].
Prevention
Identifying Risk Factors
For pancreaticoduodenectomy, a fistula risk
score has been recently developed that has been
shown to be highly predictive of POPF. This
score assigns points based on gland texture,
gland pathology, duct diameter, and intraoperative blood loss. In general, high blood loss, soft
gland texture, and smaller duct diameter confer
increased risk of POPF, whereas pancreatic adenocarcinoma and pancreatitis as the indication
for pancreaticoduodenectomy confer protection
for the development of pancreatic fistula versus other diagnoses. Also of note, higher fistula
risk scores correlated with greater incidence of
clinically relevant (ISGPF grade B or C) fistula
[9]. The adaptation of this risk score to patients
undergoing distal pancreatectomy is yet to be
validated; however, at least one published study
indicates that this scoring system may have limitations in the setting of distal pancreatectomy. In
that study, risk factors for pancreatic fistula after
stapled gland transection in patients undergoing
distal pancreatectomy were examined, and in a
multivariate analysis, only the presence of diabetes and the use of a 4.1-mm staple cartridge were
associated with increased risk of pancreatic fistula formation [10].
Some retrospective data have supported the
conclusions drawn with regard to risk for pancreatic fistula after pancreaticoduodenectomy in the
setting of distal pancreatectomy. A retrospective
case-matched analysis looked at histopathologic
features of patients with fistula and matched patient controls and found that gland fat content,
smaller main duct size, and the lack of stigmata
of chronic pancreatitis or interlobular fibrosis
were correlated with increased risk of POPF.
This study included 9 patients who underwent

31930 Preventing Pancreatic Fistula Following Distal Pancreatectomy
pancreaticoduodenectomy as well as 16 patients
who underwent distal pancreatectomy. A score
was created using these and other characteristics,
which had 92 % sensitivity and 84 % specificity
for the postoperative development of pancreatic
fistula [11].
Role of Octreotide
The somatostatin analog octreotide has been the
subject of numerous investigations in pancreatic
surgery and specifically in the prevention of the
formation of pancreatic fistula following pancreaticoduodenectomy or distal pancreatectomy.
The biologic plausibility of the effectiveness of
octreotide is significant; by decreasing pancreatic secretions, pressure gradients across the pancreatic ductal anastomosis or closure would be
decreased, thereby resulting in decreased fistula
rates. Alternatively, where a fistula has already
formed, octreotide might have the potential to
convert a high-output fistula into a low-output
fistula, decreasing the likelihood of complications and increasing the chances of a spontaneous closure. However, most studies to date have
failed to definitively identify a role for octreotide
in pancreatic surgery. Furthermore, the biologic
rationale, while emotionally appealing, may not
stand up to scientific scrutiny; a 2013 singleinstitution trial measured the effect of octreotide
in patients who underwent a pancreaticoduodenectomy by directly measuring exocrine output
using intraductal pancreatic catheters and failed
to demonstrate any significant difference between octreotide and placebo in the volume of
pancreatic exocrine secretion [12].
Recently, a multicenter randomized controlled
trial was undertaken to answer the question of
whether octreotide administration was of benefit in pancreatic surgery. Enrolling 230 patients
with slightly more than half-randomized to the
octreotide group, the study failed to demonstrate
any overall benefit in octreotide administration.
While a subgroup analysis suggested some benefit for patients with small duct diameters, the
study overall was significantly weakened by a
significant increase in the incidence of intraduct-
al fibrin sealant administration in the octreotide
group [13].
Role of Pancreatic Stenting
Stenting of the main pancreatic duct at the ampulla has been investigated as a method to prevent postoperative fistula formation after distal
pancreatectomy. This again has a clear anatomic
rationale, as decompression of the pancreatic tree
via drainage across the ampulla would have the
effect of decreasing pressure against the pancreatic stump, thereby reducing the likelihood of
leakage from the resection margin. Retrospective
data from several centers initially demonstrated
some success with the technique. One small series published in 2008 noted a 20 % incidence of
mild pancreatitis but no instances of pancreatic
leak among ten patients who underwent distal
pancreatectomy with prior endoscopic placement
of transampullary stent [14]. A second retrospective series involved the intraoperative placement
of transampullary stents. In this series, the surgeons identified the transected duct at the resection margin of the distal pancreatectomy and
subsequently advanced a pediatric feeding tube
into the duodenum. The transected end of the
duct was then ligated. The authors were able to
demonstrate an association of intraoperative stent
placement with decreased pancreatic fistula rates
as well as decreased overall length of stay [15].
However, in 2012, a randomized prospective
trial was performed in which patients were assigned either to distal pancreatectomy alone or
to distal pancreatectomy with prior transpapillary
stent placement. That trial failed to show a benefit of preoperative stenting of the pancreatic duct
and in fact demonstrated a trend toward a significantly increased rate of pancreatic fistula among
patients with preoperative stent placement [16].
An example that highlights the significant difficulty in obtaining robust best practice standards
in this area comes from a similar controversy in
pancreaticoduodenectomy. Although the operations are significantly different, prior retrospective examination of patients undergoing pancreaticoduodenectomy with intraoperative stent

320 B. D. Nath and M. P. Callery
placement demonstrated no benefit for the prevention of POPF [17]. However, a randomized
trial performed around the same time actually
demonstrated a benefit to intraoperative pancreatic stenting [18].
Dissection and Management of the Pancreatic Stump
The management of the pancreatic stump created during a distal pancreatectomy has also
been the subject of some controversy. Historically, techniques of transection of the pancreatic
stump included sharp division and oversewing
of the transected surface. With the advent of staplers, controversy has arisen with regard to their
use in transection of the pancreatic body. Some
authors initially suggested that hand-sewn closures had lower rates of fistula, whereas others
demonstrated superior results with stapler use
[19]. Recently, a multivariate analysis identified
increased thickness of the pancreatic body as a
risk factor for failure with stapled transections.
Additionally, use of a double-row (as opposed to
a triple-row) stapler load was associated with increased risk of fistula [20].
Anatomic techniques have also been widely
investigated. A recently published randomized
controlled trial compared stump reinforcement
with fibrin glue and a falciform patch to no reinforcement among patients undergoing distal pancreatectomy with stapled or hand-sutured stump
closure techniques, and found identical rates of
pancreatic fistula among the two groups [21].
Another group of techniques described in the
literature include the creation of anastomoses between the pancreatic stump and either the bowel
or the stomach. One prospective case series described 21 patients undergoing distal pancreatectomy with the creation of pancreaticogastrostomy, and the authors were able to report a 0 % rate
of grade B or C pancreatic fistula [22]. Another
group in a retrospective review demonstrated a
statistically significant elimination in the number of pancreatic fistula when a roux-en-Y limb
was brought up to provide distal drainage to the
transected pancreatic stump after distal pancre-
atectomy [23]. Indeed, numerous studies have reported somewhat favorable results with creation
of an anastomosis at the distal pancreatic stump
[24]. A large series by Kleef et al. [25] examined
302 patients undergoing distal pancreatectomy
with an overall fistula rate of 12 %. Data were
gathered prospectively, and four main techniques
of pancreatic stump management were described:
(1) pancreaticojejunostomy; (2) seromuscular
patch; (3) suture of the duct with polydioxanone
(PDS) stitch followed by parenchymal closure
with PDS suture, with or without collagen patch;
(4) closure with a stapler, primarily with a vascular load. In this series, a stapled anastomosis
was associated with a higher rate of fistula formation. As this was a retrospective, single-center
review, certain subgroup analyses such as a strict
comparison of patient characteristics between
the various closure techniques were not reported
[25]. Additionally, the use of nonvascular stapler
loads, which the authors suggest were occasionally used, may be quite significant. One singlecenter study suggested that the rate of pancreatic
fistula was much lower when a vascular (2.5 mm)
cartridge was utilized instead of a standard cartridge or a hand-sewn technique [26]. More recently, a large multicenter trial was conducted to
answer the question of whether a stapled or handsewn technique prevented POPF. The DISPACT
trial randomized patients into a stapled or handsewn closure of the pancreatic stump. The primary endpoints included combined mortality and/or
the detection of pancreatic fistula prior to postoperative day #7. Secondary endpoints included
detection of pancreatic fistula up until postoperative day #30. No difference in fistula rates was
described between the two groups. Additionally,
outcomes among a range of clinical factors were
similar. A post hoc analysis was conducted within
the trial to determine the factors associated with
the development of pancreatic fistula and did not
reveal any factor to be causative in a multivariate
analysis [27].
Ligation of the main pancreatic duct, where
technically feasible, has been reported to dramatically reduce the incidence of pancreatic duct
leak in some studies, with conflicting reports in
others. The main limitation of data addressing

32130 Preventing Pancreatic Fistula Following Distal Pancreatectomy
this technical point is that it is limited to singleinstitution retrospective studies. Some authors
have been able to demonstrate a reduction in the
rate of pancreatic fistula from greater than 30 %
to less than 10 % and that the performance of duct
ligation was a significant negative predictor of
pancreatic fistula by multivariate analysis [28].
Notably, in that study, which included an overall
pancreatic leak rate of approximately 20 %, other
factors including pancreatic pathology, handsewn or stapled closure, octreotide use, blood
transfusion, and operating time, among other
factors, were all demonstrated to be unrelated to
the postoperative development of pancreatic leak
in a multivariate analysis. A recent retrospective
review of 704 patients undergoing distal pancreatectomy at a single institution was not able to
detect a significant effect of duct ligation on the
prevention of pancreatic leak, and in fact detected a trend toward increased clinically significant
leak rate when duct ligation was performed. Of
note, however, duct ligation was employed selectively at this institution, and thus may have
been reserved for those cases with large duct
diameters or other intraoperative findings that
raised concern for increased likelihood of duct
leak [3].
There has been new interest in managing the
transected pancreatic stump by reinforcing the
stump with a mesh closure. Early retrospective
data from single centers suggested that use of
an absorbable mesh to reinforce the staple line
of the transected pancreas reduced the rate of
stump leak [29]. This method has been investigated with a randomized, single-blinded clinical
trial with a total enrollment of 100 patients. Reinforcement of the distal pancreatectomy resection
margin with mesh reduced the rate of clinically
significant (ISGPF B and C) pancreatic fistula
from 20
disadvantage
as the placement of a mesh significantly increases the cost of operation. However, a recent cost
analysis suggested that patients who received
mesh placement during distal pancreatectomy
had overall lower hospital charges and decreased
length of stay versus patients who underwent distal pancreatectomy without mesh placement [31].
% to less than 2 % [30]. One potential
of this technique relates to expense,
Minimally Invasive Versus Open Techniques
Despite advances in laparoscopic and robotic
approaches, the vast majority of distal pancreatectomies continue to be performed via an open
approach. Recent retrospective data have demonstrated that minimally invasive distal pancreatectomy is associated with decreased blood loss and
shorter hospital stays than open pancreatectomy
[32]. A large recent study utilizing the Nationwide Inpatient Sample database suggested, first,
that the minimally invasive approach is becoming more widely utilized, increasing from 2.4 to
7.3 % over a study period from 1998 to 2009.
Second, that study reported that the minimally
invasive approach was associated with decreased
length of stay as well as decreased incidence of
infectious complications, bleeding complications, and blood transfusions [33]. This population-based study echoes conclusions drawn by a
large multi-institutional study performed several
years previously. Drawing on a combined patient sample of 667 patients, with 24 % initially
attempted laparoscopically, the authors were
able to demonstrate lower overall complication
rate, decreased blood loss, and shorter hospital
stays among patients undergoing laparoscopic
approach via a multivariate analysis. Notably,
there was no significant difference in the pancreatic leak rate between the open and laparoscopic
approaches, although there was a nonsignificant
trend favoring the laparoscopic approach [34].
More recently, the robotic approach has generated significant interest as a technique for performing distal pancreatectomy. Retrospective
analysis has suggested that the robotic approach
is well suited for pancreatectomy. Fistula rates,
however, remain a concern. A retrospective review of patients undergoing robotic pancreatic
operations included 83 patients who underwent
distal pancreatectomy. About 27 % were identified as having a ISPGF type A pancreatic leak;
12 and 4.8 % were identified as having a grade
B or C leak, respectively [35]. At our own institution, we have increasingly come to utilize the
robotic approach as the operation of choice for
elective distal pancreatectomy. Early data based

322 B. D. Nath and M. P. Callery
on retrospective analyses have demonstrated no
difference between the robotic approach and the
laparoscopic approach with regard to the development of pancreatic fistula. The robotic approach, however, was associated with lower rates
of conversion to open in comparison with the
laparoscopic approach as well as shorter operative times. Additionally, oncologic outcome including nodal harvest and R0 resection were improved with the robotic approach. No significant
difference in outcome with regard to pancreatic
fistula has been demonstrated between the robotic and the laparoscopic approach [36].
Drain Placement and Management
Drain placement after pancreatectomy has been a
subject of controversy for several years. At least
one randomized trial demonstrated no benefit to
drain placement after pancreatic resection; that
trial, however, included both pancreaticoduodenectomy and distal pancreatectomy [37]. More
recently, retrospective data in patients undergoing distal pancreatectomy demonstrated that 50 %
of patients who developed pancreatic fistula were
given that diagnosis after the drain had been removed. Put another way, that data suggested that
the presence of a drain was only useful for the
detection of pancreatic fistula in 50 % of patients
[38]. Other retrospective analyses have failed to
demonstrate a benefit to peritoneal drainage after
distal pancreatectomy [39]. However, our specific practice has remained to leave a drain in place
anterior to the stapled transection margin. In our
experience, placement of a drain has the potential
to control intra-abdominal fluid collections that
form as a result of pancreatic stump leak, and we
choose to drain nearly all cases of distal pancreatectomy. Our approach to management of operative intraperitoneal drains is to monitor daily
output and remove drains when drain output is
less than 50cc per day, the character of the effluent is serous, and the patient appears clinically
well and is tolerating enteral feeding [6]. Though
admittedly a practice preference, we have seen
very few complications related to the actual drain
itself.
Management of Complications of Pancreatic Leak
Mostly, any deviation from the expected clinical course in a patient who has undergone distal
pancreatectomy should prompt consideration of a
pancreatic leak. Pancreatic leaks may present in a
latent fashion, or be clinically evident early after
resection. If a drain has been left in place, retrospective data suggest that features of the drain
prior to its removal should not be reassuring with
regard to the subsequent consideration of pancreatic fistula when a patient presents postoperatively with fever and abdominal pain. The preceding data in this chapter underscore the wide
variety of strategies that have been employed to
prevent pancreatic exocrine complications after
distal pancreatectomy and the very limited success that any single strategy has enjoyed. Indeed,
a recent survey of hepatopancreatobiliary surgeons worldwide demonstrated that there is little
consensus on the management of patients with
POPF [40].
One area where there is significant consensus
is the use of enteral nutrition. A recent single-institution randomized controlled trial demonstrated that the use of enteral, rather than parenteral,
nutrition in patients with POPF was associated
with a significantly higher rate of fistula closure
and success of conservative management. A significant caveat to the interpretation of these data
is that it includes all patients with postsurgical
pancreatic fistula, and only a minority of patients
in this study had undergone distal pancreatectomy [41]. Nonetheless, our approach in general
has been to feed enterally wherever possible.
In comparison with pancreaticoduodenectomy, collections that form after distal pancreatectomy are less likely to present with superinfection, but more likely to require prolonged
drainage. Additionally, patients with postoperative collections after distal pancreatectomy were
more likely to present in a latent fashion after
discharge [42].
Ductal disruption after distal pancreatectomy
can lead to a variety of complications, each of
which has different specific management strategies. In general, we manage patients using the

32330 Preventing Pancreatic Fistula Following Distal Pancreatectomy
ISPGF criteria. Patients with grade A or B leaks
are managed conservatively, with grade B patients often requiring inpatient management with
observation, hydration, and antibiotics.
Rarely, we have come across patients that
have developed complications such as pancreatic
pseudocyst following distal pancreatectomy. Our
essential approach to managing these patients involves four steps. The first principle is resuscitation toward goal-directed endpoints and adequate
infection control pending further management.
The second is adequate anatomic information,
particularly with regard to main pancreatic duct
disruption and ongoing fistulous formation, with
endoscopic intervention where necessary. The
third is optimization of the patient to undergo
prolonged conservative management, including
careful attention to nutritional status, ongoing
antibiotics if indicated, judicious management of
electrolyte abnormalities, and overall attention to
physical and psychological well-being. Fourth,
when intervention is necessary, a strategy of deliberate reintervention is preferred.
Goal-Directed Resuscitation and Infection Control
The patient presenting with latent pancreatic leak
or pseudocyst frequently will present with complaints of abdominal pain, fever, nausea, or vomiting. In more dramatic cases, full-blown signs
of sepsis or even shock may be present. Initially,
we manage these patients as we would any other
postoperative intra-abdominal complication. Resuscitation with crystalloid proceeds expeditiously with a goal of maintaining adequate tissue perfusion. Hence, urine output is followed closely,
with placement of a Foley catheter if there is any
uncertainty as to whether adequate urine output
can be recorded. Full laboratory studies, urinalysis, and blood cultures are obtained, and initial
imaging studies including a contrast abdominal
computed tomography scan are obtained. After
blood cultures are drawn, antibiotic therapy is
administered empirically. Individual patient-specific data on history of resistant organisms and
institution-specific resistance patterns are con-
sidered. Often the combination of vancomycin
and a carbapenem is selected for adequate penetration into a potential pseudocyst cavity. Signs
of severe infection, such as necrotizing features
or evidence of gas-forming bacteria within the
fluid collection, typically require prompt drainage, either surgically or through radiographic
means. Prompt initiation of vasopressor support
and observation in a monitored bed are pursued
as clinically indicated.
Further Definition of Anatomy and Source Control
The next key decision point involves defining the
anatomic basis of the patient’s complication and
offering targeted interventions where appropriate. Where CT imaging has not provided sufficient data, Magnetic resonance cholangiopancreatography (MRCP) may be pursued at this point,
which has the significant advantage of imaging
of pancreatic ductal disruption. In most cases,
we prefer obtaining an MRCP prior to considering endoscopic intervention. However, where
evidence of ongoing ductal leak is evident, endoscopic retrograde cholangiopancreatography
with sphincterotomy and stent placement is pursued in order to decompress the pancreatic ductal
system. Lastly, if the clinical status warrants percutaneous intervention, IR-guided drain placement may be considered. Our primary consideration in this regard is the clinical status of the patient and the appearance of concerning features,
such as gas within the pseudocyst collection.
Optimizing Patient Clinical Status for Ongoing Conservative Management
Postoperative complications such as pancreatic
fistula or pseudocyst are significant, physically
and emotionally challenging complications for
patients to endure. Scrupulous attention to the
maintenance of the patients’ well-being as they
suffer the ordeal of prolonged hospitalization or
external drainage is mandatory. Careful attention
to ongoing fluid losses and electrolyte abnor-

324 B. D. Nath and M. P. Callery
malities can minimize physiologic stress. Additionally, it is not likely that patients can maintain
adequate caloric intake in the face of the psychological stress as well as the physical discomfort
attendant on such a complication. Consequently,
we initiate supplemental enteral nutrition quickly, with the recognition that supplemental feeding
via a Dobhoff tube can place its own burden on
the patient. Parenteral nutrition is avoided wherever possible. Antibiotics are typically continued
for several weeks in the absence of definitive
source control. Careful coordination of resources is necessary if patients are to continue these
treatments on an outpatient basis, whether at a
rehabilitation hospital or at home. Intraperitoneal
drains, whether present from the initial operation
or placed under radiologic guidance, are maintained until output has ceased or until further surgical intervention is pursued.
Deliberate Reintervention When Clinically Indicated
Summary
Left pancreatectomy is an attractive operation for
patients with distal pancreatic disease. Nonetheless, despite significant investigation in this area,
high rates of POPF are reported across multiple
centers. Few technical modalities have been conclusively shown to prevent this complication. Recent studies indicating a role for mesh reinforcement of the staple line are encouraging, but will
require further external validation. We anticipate
continued growth in minimally invasive and robotic approaches. The adaptation of technical
modalities to the minimally invasive approach
may yield further improvements in preventing
the complication of pancreatic stump leak. The
management of the complication of pancreatic
leak with or without formation of pseudocyst
requires careful multidisciplinary strategies. The
role of the surgeon in caring for the patient with a
postoperative pancreatic leak is critical to a successful outcome and a healthy patient.
Our final approach involves reintervention when
clinically indicated, preferably with minimally
invasive approaches whenever necessary. The
majority of patients with this complication will
resolve with conservative management. However, when a persistent pseudocyst has formed
and is causing ongoing abdominal symptoms,
surgical and occasionally endoscopic procedures
such as cyst gastrostomy or cyst jejunostomy are
considered (when a nonresolving mature pseudocyst exists). Another useful operation is internal
drainage of a mature fistula tract to the jejunum,
avoiding the temptation to dissect to the actual
origin location of the leak. Typically operative
planning requires repeat MRCP in order to define
whether ongoing ductal disruption is present. Repeat ERCP with stent exchange is considered on
a case-by-case basis.
Key Points on Avoiding Complications
1. Consider gland texture, duct diameter, and
gland thickness when transecting pancreatic
body. Use triple-row stapler when technically
feasible.
2. Consider mesh placement to reinforce staple
line.
3. Octreotide administered perioperatively has
never been demonstrated to provide benefit,
but is utilized by a number of centers given its
low cost and relative ease of administration.
4. Minimally invasive distal pancreatectomy has
not been demonstrated to be superior to open
pancreatectomy in terms of overall fistula
rates, but is associated with decreased blood
loss and shorter overall hospital stay.
5. When performed, enteric anastomoses to the
distal pancreatic transection margin are associated with low rates of fistula formation, but
are infrequently utilized.

32530 Preventing Pancreatic Fistula Following Distal Pancreatectomy
Key Points on Diagnosis/ Management of Complications
1. Consider pancreatic leak in the differential diagnosis of any patient who undergoes distal
pancreatectomy and experiences a significant
deviation from the postoperative course.
2. No more than 50 % of pancreatic leaks are
likely to be detected on the basis of intraperitoneal drains, and axial imaging may reveal
no anatomic abnormality in the setting of high
drain output.
Enteral nutrition is preferred
3.
wherever possible and is associated with increased rates of
spontaneous fistula closure.
Endoscopic and surgical techniques
4.
may be
considered for patients who develop persistent
fistula or complications such as pseudocyst.
When a pseudocyst develops, consider all
5.
multidisciplinary approaches, as sur
gical rein-
tervention can often be avoided.
References
1. Cogbill TH, Moore EE, Morris JA Jr, Hoyt DB,
Jurkovich GJ, Mucha P Jr, et al. Distal pancreatectomy for trauma: a multicenter experience. J Trauma.
1991;31(12):1600–6.
2.
Callery MP, Pratt
management of pancreatic fistula. J Gastrointest Surg.
2009;13(1):163–73.
3.
Nathan H, Cameron JL, Goodwin CR, Seth
Edil BH, Wolfgang CL, et
leak after distal pancreatectomy. Ann Surg.
creatic
2009;250(2):277–81.
4.
Bassi C, Dervenis C, Butturini G, Fingerhut A,
C, Izbicki J, et al. Postoperative pancreatic fistula: an
international study group (ISGPF) definition. Surgery.
2005;138(1):8–13.
5. Pratt WB, Callery MP, Vollmer CM Jr. Risk prediction for development of pancreatic fistula using
the ISGPF classification scheme. World J Surg.
2008;32(3):419–28.
6. Pratt WB, Callery MP, Vollmer CM Jr. The latent
presentation of pancreatic fistulas. Br J Surg.
2009;96(6):641–9.
7. Facy O, Chalumeau C, Poussier M, Binquet C, Rat P,
Ortega-Deballon P. Diagnosis of postoperative pancreatic fistula. Br J Surg. 2012;99(8):1072–5.
8. Pratt W, Maithel SK, Vanounou T, Callery MP,
Vollmer CM Jr. Postoperative pancreatic fistulas are
not equivalent after proximal, distal, and central pancreatectomy. J Gastrointest Surg. 2006;10(9):1264–
78. Discussion 78–9.
WB, Vollmer CM Jr. Prevention and
AK,
al. Risk factors for pan-
Yeo
9. Callery MP, Pratt
CM Jr. A prospectively validated clinical risk score
accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1–14.
10. Subhedar PD, Patel SH, Kneuertz
Staley CA, Sarmiento JM, et al. Risk factors for pan-
fistula after stapled gland transection. Am
creatic
Surg. 2011;77(8):965–70.
Belyaev O, Munding J, Herzog T, Suelberg D, Tan-
11.
napfel A, Schmidt WE, et
features of the pancreatic remnant as
risk factors for postoperative pancreatic fistula: a
matched-pairs analysis. Pancreatology. 11(5):516–
24.
12.
Fernandez-Cruz L, Jimenez Chavarria E, Taura P,
Closa D, Boado MA, Ferrer J. Prospective randomized trial of the effect of octreotide on pancreatic
juice output after pancreaticoduodenectomy in relation to histological diagnosis, duct size and leakage.
HPB (Oxford). 2013;15(5):392–9.
Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM,
13.
Flamant Y
abdominal complications following elective pancreatic resection: a prospective, multicenter randomized
controlled trial. Arch Surg. 2004;139(3):288–94.
Discussion 95.
14. Abe N, Sugiyama M, Suzuki Y, Yamaguchi T, Mori
T, Atomi Y. Preoperative endoscopic pancreatic
stenting: a novel prophylactic measure against pancreatic fistula after distal pancreatectomy. J Hepatobiliary Pancreat Surg. 2008;15(4):373–6.
15.
Fischer CP, Bass B, Fahy B, Aloia
pancreatic duct stenting decreases pancreatic fistula
rate following left pancreatectomy. Hepatogastroenterology. 2008;55(81):244–8.
16. Frozanpor F, Lundell L, Segersvard R, Arnelo U. The
effect of prophylactic transpapillary pancreatic stent
insertion on clinically significant leak rate following
distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg. 2012;255(6):1032–6.
17. Sachs TE, Pratt WB, Kent TS, Callery MP, Vollmer
CM Jr. The pancreaticojejunal anastomotic stent:
friend or foe? Surgery. 2013;153(5):651–62.
18. Motoi F,
Randomized clinical trial of external stent drainage
of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy. Br J Surg.
2012;99(4):524–31.
19. Ban D, Shimada K, Konishi M, Saiura A,
M, Uesaka K. Stapler and nonstapler closure of the
pancreatic remnant after distal pancreatectomy: multicenter retrospective analysis of 388 patients. World
J Surg. 2012;36(8):1866–73.
20. Sugimoto M, Gotohda N, Kato Y, Takahashi S,
Kinoshita T, Shibasaki H, et al. Risk factor analysis
and prevention of postoperative pancreatic fistula after distal pancreatectomy with stapler use. J Hepatobiliary Pancreat Sci. 2013;20(5):538–44.
WB, Kent TS, Chaikof EL, Vollmer
PJ, Maithel SK,
al. Histomorphological
al. Octreotide in the prevention of intra-
, et
Egawa S, Rikiyama T, Katayose Y, Unno M.
independent
T. Transampullary
Hashimoto

326 B. D. Nath and M. P. Callery
21. Carter TI, Fong ZV, Hyslop T, Lavu H, Tan WP,
Hardacre J, et
trolled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and
fibrin glue improve outcomes? J Gastrointest Surg.
2013;17(1):102–9.
22.
Sudo T, Murakami
Hashimoto Y, Nakashima A, et
tomy with duct-to-mucosa pancreaticogastrostomy:
novel technique for preventing postoperative pancreatic fistula. Am J Surg. 2011;202(1):77–81.
23. Wagner M, Gloor B, Ambuhl M, Worni M, Lutz JA,
Angst E, et
stump decreases pancreatic fistula after distal pancreatic resection. J Gastrointest Surg. 2007;11(3):303–8.
24.
Meniconi RL, Caronna R, Borreca D, Schiratti
Chirletti P. Pancreato-jejunostomy versus hand-sewn
closure of the pancreatic stump to prevent pancreatic
fistula after distal pancreatectomy: a retrospective
analysis. BMC Surg. 2013;13:23.
25.
Kleeff J, Diener MK, Z’Graggen
M, Bachmann J, et
for surgical failure in 302 consecutive cases.
factors
Ann Surg. 2007;245(4):573–82.
26.
Sepesi B, Moalem J, Galka E, Salzman P
LO. The influence of staple size on fistula formation
following distal pancreatectomy. J Gastrointest Surg.
2012;16(2):267–74.
27.
Diener MK, Seiler CM, Rossion I, Kleeff J, Glane
mann M, Butturini G, et
hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial.
Lancet. 2011;377(9776):1514–22.
28.
Bilimoria MM, Cormier JN, Mun
DB, Pisters PW. Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. Br J Surg. 2003;90(2):190–6.
29.
Thaker RI, Matthews BD, Linehan DC, Strasber
SM, Eagon JC, Hawkins WG. Absorbable mesh reinforcement of a stapled pancreatic transection line
reduces the leak rate with distal pancreatectomy. J
Gastrointest Surg. 2007;11(1):59–65.
30.
Hamilton NA, Porembka MR, Johnston
Strasberg SM, Linehan DC, et
ment of pancreatic transection decreases incidence of
pancreatic occlusion failure for left pancreatectomy:
a single-blinded, randomized controlled trial. Ann
Surg. 2012;255(6):1037–42.
31.
Idrees K, Edler JR, Linehan DC, Strasberg SM,
Jacques D, Hamilton
of mesh
my. HPB (Oxford). 2013;15(11):898–993.
reinforcement of stapled left pancreatecto-
dual-institution randomized con-
al. A
Y, Uemura K, Hayashidani Y,
al. Roux-en-Y drainage
al. Distal pancreatectomy: risk
NA, et
al. Distal pancreatec-
K, Hinz U, Wagner
al. Efficacy
al. Mesh reinforce
al. Cost benefit analysis
of the pancreatic
M,
, Schoeniger
of stapler versus
Y, Lee JE, Evans
FM, Gao F,
32.
Magge D, Gooding W, Choudry H, Steve
J, Zureikat A, et
minimally invasive and open distal pancreatectomy for ductal adenocarcinoma. JAMA Surg.
2013;148(6):525–31.
33. Tran Cao HS, Lopez N, Chang DC, Lowy AM, Bouvet M, Baumgartner JM, et
tive outcomes with minimally invasive
a
-
g
-
atectomy: results from a population-based analysis.
JAMA Surg. 149(3):237–43.
34.
Kooby DA, Gillespie T, Bentrem
Schmidt MC, Merchant NB, et
atectomy: a multicenter
and open approaches. Ann Surg. 2008;248(3):438–
46.
35.
Zureikat AH, Moser AJ, Boone
nati M, Zeh HJ 3rd. 250 robotic pancreatic resections:
safety and feasibility. Ann Surg. 2013;258(4):554–9.
Discussion 9–62.
36.
Daouadi M, Zureikat AH, Zenati
Tsung A, Bartlett DL, et
invasive distal pancreatectomy is superior to the lap
aroscopic technique. Ann Surg. 2013;257(1):128–32.
37. Conlon KC, Labow D, Leung D, Smith A, Jarnagin
W, Coit DG, et al. Prospective randomized clinical
trial of the value of intraperitoneal drainage after
pancreatic resection. Ann Surg. 2001;234(4):487–93.
Discussion 93–4.
38.
Pannegeon V, Pessaux P
MP, Kianmanesh R, Belghiti J. Pancreatic fistula
after distal pancreatectomy: predictive risk factors
and value of conservative treatment. Arch Surg.
2006;141(11):1071–6. Discussion 6.
39.
Paulus EM, Zarzaur
peritoneal drainage of the surgical bed after elective
distal pancreatectomy: is it necessary? Am J Surg.
2012;204(4):422–7.
40. Melloul E, Raptis DA, Clavien P
level of agreement on the management of postoperative pancreatic fistula: results of an international survey. HPB (Oxford). 2013;15(4):307–14.
41.
Klek S, Sierzega M, Turczynowski L, Szybinski P,
Szczepanek K, Kulig J. Enteral and parenteral nutrition in the conservative treatment of pancreatic fistula: a randomized clinical trial. Gastroenterology.
2011;141(1):157–63, 63 e1.
42.
, Sima CS, Getrajdman GI, Brown KT, Covey
Vin Y
A, Brennan MF, et
postpancreatectomy
of 908 patients resected at a single institution between
2000 and 2005. J Am Coll Surg. 2008;207(4):490–8.
al. Comparative ef
al. Improved periopera-
comparison of laparoscopic
al. Robot-assisted minimally
, Sauvanet A, Vullierme
BL, Behrman SW. Routine
al. Management and outcomes of
fistula, leak, and abscess: results
fectiveness of
distal pancre-
D, Nakeeb A,
al. Left-sided pancre-
BA, Bartlett DL, Ze-
MS, Choudry H,
A, Lesurtel M. Poor
J, Steel
-
Соседние файлы в папке Библиотека им академика М.И. Перельмана
